125
Views
4
CrossRef citations to date
0
Altmetric
Articles

Influence of antiretroviral therapy and cardiovascular disease on the immature platelet fraction in patients living with HIV

ORCID Icon, , , , , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 756-762 | Received 20 May 2019, Accepted 02 Oct 2019, Published online: 13 Oct 2019

References

  • Teeraananchai S, Kerr S, Amin J, Ruxrungtham K, Law M. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med 2017;18(4):256–266. doi:10.1111/hiv.12421
  • May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, D’Arminio Monforte A, Casabona J, Hogg RS, Mocroft A, et al. Cohort profile: antiretroviral Therapy Cohort Collaboration (ART-CC). Int J Epidemiol 2014;43(3):691–702. doi:10.1093/ije/dyt010
  • Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A, Burns F, Copas A, Brown AE, Sullivan AK, et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health 2017;2(1):e35–e46. doi:10.1016/S2468-2667(16)30020-2
  • Freiberg MS, Chang -C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Goetz MB, Leaf D, Oursler KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013;173(8):614–622. doi:10.1001/jamainternmed.2013.3728
  • Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, Rimland D, Rodriguez‐Barradas MC, Oursler KK, Brown ST, et al. Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers. HIV Med 2010;11(2):143–151. doi:10.1111/j.1468-1293.2009.00757.x
  • Cerrato E, Calcagno A, D’Ascenzo F, Biondi-Zoccai G, Mancone M, Marra WG, Demarie D, Omedè P, Abbate A, Bonora S, et al. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart 2015;2(1):e000174. doi:10.1136/openhrt-2014-000174
  • Gresele P, Falcinelli E, Sebastiano M, Baldelli F. Endothelial and platelet function alterations in HIV-infected patients. Thromb Res 2012;129(3):301–308. (XI ETRO ADVANCED TEACHING COURSE “Thrombosis: a multidisciplinary approach” September 18-23, 2011, Campobasso, Italy). doi:10.1016/j.thromres.2011.11.022
  • Nkambule BB, Davison GM, Ipp H. The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals. Int J Lab Hematol 2015;37(4):450–458. doi:10.1111/ijlh.12307
  • Kuller LH, Tracy R, Belloso W, Wit SD, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008;5(10):e203. doi:10.1371/journal.pmed.0050203
  • Ledwaba L, Tavel JA, Khabo P, Maja P, Qin J, Sangweni P, Liu X, Follmann D, Metcalf JA, Orsega S, et al. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. PLoS One 2012;7(3):e24243. doi:10.1371/journal.pone.0024243
  • Schneider S, Spinner CD, Cassese S, Promny D, Hapfelmeier A, Byrne RA, Baumann M, Jäger H, Steinlechner E, Laugwitz K-L, et al. Association of increased CD8+ and persisting C-reactive protein levels with restenosis in HIV patients after coronary stenting. AIDS 2016;30(9):1413–1421. doi:10.1097/QAD.0000000000001063
  • Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, et al. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr 2011;56(1):36–43. doi:10.1097/QAI.0b013e3181f7f61a
  • Jong E, Louw S, van Gorp ECM, Meijers JCM, Ten Cate H, Jacobson BF. The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost 2010;104(6):1228–1234. doi:10.1160/TH10-04-0233
  • O’Halloran JA, Dunne E, Gurwith MMP, Lambert JS, Sheehan GJ, Feeney ER, Pozniak A, Reiss P, Kenny D, Mallon PWG. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV‐1 infection. HIV Med 2015;16(10):608–619. doi:10.1111/hiv.12270
  • Landrø L, Ueland T, Otterdal K, Frøland SS, Aukrust P. Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy. J Thromb Haemost 2011;9(5):1075–1077. doi:10.1111/j.1538-7836.2011.04242.x
  • Satchell CS, O’Halloran JA, Cotter AG, Peace AJ, O’Connor EF, Tedesco AF, Feeney ER, Lambert JS, Sheehan GJ, Kenny D, et al. Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy. J Infect Dis 2011;204(8):1202–1210. doi:10.1093/infdis/jir509
  • Gresele P, Falcinelli E, Momi S, Francisci D, Baldelli F. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations. Rev Cardiovasc Med 2014;15(Suppl 1):S9–20.
  • Thon JN, Italiano JE. Does size matter in platelet production?. Blood 2012;120(8):1552–1561. doi:10.1182/blood-2012-04-408724
  • Bongiovanni D, Santamaria G, Klug M, Santovito D, Felicetta A, Hristov M, von Scheidt M, Aslani M, Cibella J, Weber C, et al. Transcriptome Analysis of Reticulated Platelets Reveals a Prothrombotic Profile. Thromb Haemost 2019. [Epub ahead of print]. doi:10.1055/s-0039-1695009
  • Hong KH, Kim HK, Kim J-E, Jung JS, Han K-S, Cho H-I. Prognostic value of immature platelet fraction and plasma thrombopoietin in disseminated intravascular coagulation. Blood Coagulation Fibrinolysis 2009;20(6):409–414. doi:10.1097/MBC.0b013e32832b1866
  • Garibaldi B, Malani R, Yeh H-C, Lipson E, Michell D, Bennett M, Moliterno A, McDevitt MA, Kickler TS. Estimating platelet production in patients with HIV-related thrombocytopenia using the immature platelet fraction. Am J Hematol 2009;84(12):852–854. doi:10.1002/ajh.21559
  • Vaughan J, Wiggill T, Munster M. Immature platelet fraction levels in a variety of bone marrow pathologies in South African HIV-positive patients with thrombocytopenia. Hematology 2014;19(7):417–423. doi:10.1179/1607845413Y.0000000143
  • Adly AAM, Ragab IA, Ismail EAR, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets 2015;26(7):645–650. doi:10.3109/09537104.2014.969220
  • Hubert RME, Rodrigues MV, Andreguetto BD, Santos TM, de Fátima Pereira Gilberti M, de Castro V, Annichino-Bizzacchi JM, Dragosavac D, Carvalho-Filho MA, De Paula EV. Association of the immature platelet fraction with sepsis diagnosis and severity. Sci Rep 2015;5:8019. doi:10.1038/srep08019
  • Muronoi T, Koyama K, Nunomiya S, Lefor AK, Wada M, Koinuma T, Shima J, Suzukawa M. Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsis. Thromb Res 2016;144:169–175. doi:10.1016/j.thromres.2016.06.002
  • Ibrahim H, Schutt RC, Hannawi B, DeLao T, Barker CM, Kleiman NS. Association of immature platelets with adverse cardiovascular outcomes. J Am Coll Cardiol 2014;64(20):2122–2129. doi:10.1016/j.jacc.2014.06.1210
  • Cesari F, Marcucci R, Gori AM, Caporale R, Fanelli A, Casola G, Balzi D, Barchielli A, Valente S, Giglioli C, et al. Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Thromb Haemost 2013;109(5):846–853. doi:10.1160/TH12-09-0709
  • Anetsberger A, Blobner M, Haller B, Schmid S, Umgelter K, Hager T, Langgartner C, Kochs EF, Laugwitz K-L, Jungwirth B, et al. Immature platelets as a novel biomarker for adverse cardiovascular events in patients after non-cardiac surgery. Thromb Haemost 2017;117(10):1887–1895. doi:10.1160/TH16-10-0804
  • Robinson M, MacHin S, MacKie I, Harrison P. Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV+ samples. Platelets 2001;12(2):108–113. doi:10.1080/09537100020047093
  • Ibrahim H, Nadipalli S, Usmani S, DeLao T, Green L, Kleiman NS. Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection. J Thromb Thrombolysis 2016;42(1):77–83. doi:10.1007/s11239-016-1338-3
  • Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010;8(1):148–156. doi:10.1111/j.1538-7836.2009.03584.x
  • Lee EY, Kim SJ, Song YJ, Choi SJ, Song J. Immature platelet fraction in diabetes mellitus and metabolic syndrome. Thromb Res 2013;132(6):692–695. doi:10.1016/j.thromres.2013.09.035
  • Mijovic R, Kovacevic N, Zarkov M, Stosic Z, Cabarkapa V, Mitic G. Reticulated platelets and antiplatelet therapy response in diabetic patients. J Thromb Thrombolysis 2015;40(2):203–210. doi:10.1007/s11239-014-1165-3
  • Verdoia M, Pergolini P, Nardin M, Rolla R, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G. Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy. J Thromb Thrombolysis 2016;42(2):245–253. doi:10.1007/s11239-016-1348-1
  • Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF, Abbate R, Gori AM. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost 2008;99(5):930–935. doi:10.1160/TH08-01-0002
  • Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126(1):93–99. doi:10.1111/j.1365-2141.2004.04987.x
  • Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS 2014;9(1):80–86. doi:10.1097/COH.0000000000000019
  • Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS 2010;24(10):1509–1517. doi:10.1097/QAD.0b013e32833ad914
  • Koenig W, Rothenbacher D, Hoffmeister A, Griesshammer M, Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Arterioscler Thromb Vasc Biol 2001;21(10):1701–1705. doi:10.1161/hq1001.097020
  • Shi X, Sims MD, Hanna MM, Xie M, Gulick PG, Zheng Y-H, Basson MD, Zhang P. Neutropenia during HIV infection: adverse consequences and remedies. Int Rev Immunol 2014;33(6):511–536. doi:10.3109/08830185.2014.893301

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.